Skip to search formSkip to main contentSkip to account menu

AICARDI-GOUTIERES SYNDROME 3

Known as: AGS3 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Abstract The Aicardi–Goutières syndrome (AGS) was first described in 1984, and over the following years was defined by the… 
Highly Cited
2010
Highly Cited
2010
Although several non-receptor activators of heterotrimeric G proteins have been identified, the structural features of G proteins… 
2010
2010
Agrotis segetum Schiff. (Lepidoptera: Noctuidae) is one of the most serious pests of nearly all vegetables in Turkey. In this… 
Highly Cited
2008
Highly Cited
2008
Activator of G‐protein Signaling (AGS) 3 and AGS5/LGN, via regulation of G‐protein signaling, play central functional roles in… 
Highly Cited
2005
Highly Cited
2005
Neurons in the developing mammalian brain are generated from progenitor cells in the proliferative ventricular zone, and control… 
Review
2004
Review
2004
The GoLoco motif is a 19-amino-acid sequence with guanine nucleotide dissociation inhibitor activity against G-alpha subunits of… 
Highly Cited
2001
Highly Cited
2001
AGS3 (activator ofG-protein signaling 3) was isolated in a yeast-based functional screen for receptor-independent activators of… 
Highly Cited
2000
Highly Cited
2000
The G-protein regulatory (GPR) motif in AGS3 was recently identified as a region for protein binding to heterotrimeric G-protein…